From hereEven old shareholders and posters are back to give their opinion here as we are all smashed with that 52 year low......
And a lot are OVER-invested here. Me first.
Is it possible to point out why (1); and what will it take (2) for this ship to really "TURN THE CORNER" (oh boy, we all called that moment to early.......).
First "WHY";
- Last two quarter should have been profitable; even if analyst came saying at the last conference call "Hey bravo for the results".......what was behind the words was: "you mist again !";
- Trogarzo penetration rate is so low that a lot are making the parallel with Egrifta that never met initial expectations;
- The confidence that this company will ever be profitable is a killer right now; add to that, the next quarterly result are in july ! That is an eternity for investors who (a lot...) are looking for short term results; so huge risk of $ movement in the short term to sectors that are soaring;
Second "What will it take";
- Turning the corner means, a couple of quarters with impressive (that is what ? 30% increase) sales growth for TROGARZO (first) and good trend for EGRIFTA (? %);
- Profits in the bottom line from now on;
- Rapidly give their plan for all the NASH field.
******
The problem I see here, and I would like your opinion on that, is that all the NASH field is interesting, and I was really surprised : BUT IT MEANS EXPENSES FOR THE NEXT QUARTERS as for KATANA developement. EXPENSES are also for the EUROPEAN development (and that is a lot of $$$$): EGRIFTA; TROGARZO. A lot of new employees. A lot of money going out...........
Will Tanguay and TH/THERF be able to play the game (its a hard one) and be able to deal with EXPANSION and PROFITABILITY ?
In my sense, it all depends on TROGARZO and EGRIFTA sales. You go upon 30% sales improvement and you declare a profit.............you have a hard time selling the drugs, we stay in the red. If you stay in the red..........the share price will stay low.
Lets say it...........NASH egals in the short term money going OUT, not in.
FTV.